Literature DB >> 35951134

Glissonian Approach During Robotic Mesohepatectomy for Recurrent Colorectal Liver Metastasis.

Marcel Autran C Machado1, Bruno V Mattos2, Murillo Macedo Lobo Filho2, Fabio Makdissi2.   

Abstract

Entities:  

Year:  2022        PMID: 35951134     DOI: 10.1245/s10434-022-12331-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  3 in total

1.  Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka.

Authors:  Go Wakabayashi; Daniel Cherqui; David A Geller; Joseph F Buell; Hironori Kaneko; Ho Seong Han; Horacio Asbun; Nicholas OʼRourke; Minoru Tanabe; Alan J Koffron; Allan Tsung; Olivier Soubrane; Marcel Autran Machado; Brice Gayet; Roberto I Troisi; Patrick Pessaux; Ronald M Van Dam; Olivier Scatton; Mohammad Abu Hilal; Giulio Belli; Choon Hyuck David Kwon; Bjørn Edwin; Gi Hong Choi; Luca Antonio Aldrighetti; Xiujun Cai; Sean Cleary; Kuo-Hsin Chen; Michael R Schön; Atsushi Sugioka; Chung-Ngai Tang; Paulo Herman; Juan Pekolj; Xiao-Ping Chen; Ibrahim Dagher; William Jarnagin; Masakazu Yamamoto; Russell Strong; Palepu Jagannath; Chung-Mau Lo; Pierre-Alain Clavien; Norihiro Kokudo; Jeffrey Barkun; Steven M Strasberg
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

2.  Robotic Repeat Right Hepatectomy for Recurrent Colorectal Liver Metastasis.

Authors:  Marcel Autran Machado; Rodrigo C Surjan; Tiago Basseres; Fabio Makdissi
Journal:  Ann Surg Oncol       Date:  2018-11-09       Impact factor: 5.344

3.  Institutional First 100 Case Experience and Outcomes of Robotic Hepatectomy for Liver Tumors.

Authors:  Iswanto Sucandy; Andres Giovannetti; Sharona Ross; Alexander Rosemurgy
Journal:  Am Surg       Date:  2020-03-01       Impact factor: 0.688

  3 in total
  1 in total

1.  ASO Author Reflections: Glissonian Approach is Useful in Robotic Liver Resections.

Authors:  Marcel Autran Machado; Fabio Makdissi
Journal:  Ann Surg Oncol       Date:  2022-08-22       Impact factor: 4.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.